Cardio Mag 2.0
Fully-reacted magnesium orotate for cardiovascular support*
- Supports a healthy heart and healthy cells
- Helps increase energy production in the heart
- Promotes improvement in athletic performance
$44.96 — or subscribe and save 20%
Out of stock
AOR’s Cardio Mag 2.0 is the ideal supplement for those looking to maintain healthy magnesium levels that may help improve athletic performance and support healthy cells. The formula contains true, fully reacted magnesium orotate. Orotate, in addition to being a carrier for magnesium, also has heart-health benefits.
An important part of leading a healthy lifestyle is supporting a strong, healthy heart. Being proactive in taking care of our health often requires more than exercise and balanced eating habits. Making sure we maintain necessary levels of magnesium in the body is a great way to supplement our nutritional needs. Magnesium offers many benefits, such as promoting bone formation, assimilating calcium into the bones, helping to activate vitamin D in the kidneys, as well as supporting the proper functioning of dozens of enzymes.
AOR’s formula combines magnesium with orotic acid to deliver the best support. Magnesium is known to be an important mineral for the heart. Orotic acid, in addition to being a carrier for magnesium, also has heart-health benefits such as supporting cellular repair, cardiac energy stores, energy levels, and protein synthesis. Orotic acid supports RNA synthesis, the precursor to DNA production, by strengthening and restoring the cellular function of heart cells under stress. Magnesium also plays a very important role in the normal functioning of cells, nerves, muscles and bones.
Cardio Mag 2.0 is a fully reacted and pure form of magnesium orotate in an effective dose for cardiovascular support.
The magnesium orotate in AOR’s Cardio Mag 2.0 is fully-reacted, unlike most products which are food-grade mixtures of orotic acid with inorganic magnesium salts. This true magnesium orotate combines two compounds important for optimal cardiovascular function.*
AOR™ guarantees that all ingredients have been declared on the label. Contains no wheat, gluten, corn, nuts, peanuts, sesame seeds, sulfites, mustard, soy, dairy, eggs, fish, shellfish or any animal byproduct.
Take one capsule one to four times daily with food, or as directed by a qualified health care practitioner.
Consult a health care practitioner if you are pregnant or lactating or if you have a medical condition, or are taking any medication. Keep out of reach of children.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
† Daily Value not established.
Other Ingredients: organic rice hulls.
Capsule: hypromellose and purified water.
Domnitskaia TM, D’iachenko AV, Kupriianova OO, Domnitskii MV. Clinical value of the use of magnesium orotate in adolescents with syndrome of cardiac connective tissue dysplasia. Kardiologiia. 2005;45(3):76-81.
Gaita D, Branea I, Dragulescu SI, et al. Benefit of treatment with magnesium orotate in patients with chronic heart failure in early postoperative period after coronary artery by-pass grafting. Gavan N. Hjertforum. 2001 Aug; 14(3): 78.
Geiss KR, Stergiou N, Jester, Neuenfeld HU, Jester HG. Effects of magnesium orotate on exercise tolerance in patients with coronary heart disease. Cardiovasc Drugs Ther. 1998 Sep; 12 Suppl 2:153-6.
Golf SW, Bender S, Gruttner J. On the significance of magnesium in extreme physical stress. Cardiovasc Drugs Ther. 1998 Sep;12 Suppl 2:197-202.
Nieper HA. Capillarographic criteria on the effect of magnesium orotate, EPL substances and clofibrate on the elasticity of blood vessels. Agressologie. 1974; 15(1): 73-7.
Rosenfeldt F, Miller F, Nagley P, et al. Response of the senescent heart to stress: clinical therapeutic strategies and quest for mitochondrial predictors of biological age. Ann N Y Acad Sci. 2004 Jun; 1019:78-84.
Stepura OB, Tomaeva FE, Zvereva TV. Orotic acid as a metabolic agent. Vestn Ross Akad Med Nauk. 2002; (2): 39-41.